Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Treatment for Necrobiosis Lipoidica Gets Orphan Drug Designation

Treatment for Necrobiosis Lipoidica Gets Orphan Drug Designation

By

The FDA has granted Orphan Drug Designation to PCS499 (Processa Pharmaceuticals) for the treatment of necrobiosis lipoidica.

FDA Approves Updated Labeling for Two Obesity Treatments

FDA Approves Updated Labeling for Two Obesity Treatments

By

Specifically, the new labeling includes updated data on the global rate of occurrence related to these adverse events.

Skin Nodule Manipulation Leads to Adverse Drug Reactions in a T2D Patient

Skin Nodule Manipulation Leads to Adverse Drug Reactions in a T2D Patient

By

The patient, a 50-year old male, presented to the emergency department with palpitations and complaints of nausea, retching and diarrhea which he said started after he squeezed a nodule on his thigh.

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

By

The Food and Drug Administration has posted a recall notification for 2 lots of Riomet 500mg/5mL due to the possibility that the liquid may be contaminated with Scopulariopsis brevicaulis.

FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels

FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels

By

One patient taking high levels of biotin has died following falsely low troponin test results when a troponin test known to have biotin interference was used.

More Articles by Diana Ernst, RPh

Sign Up for Free e-Newsletters



CME Focus